Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases

We present the cases of three patients with severe, life-threatening coronavirus disease 2019 (COVID-19) who had failed to achieve substantial improvement on intial treatment. They subsequently received pulse therapy with methylprednisolone [1,000 mg/day intravenously (IV) for three consecutive days...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheianov, Mikhail V, Udalov, Yurii D, Ochkin, Sergei S, Bashkov, Andrei N, Samoilov, Aleksandr S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343298/
https://www.ncbi.nlm.nih.gov/pubmed/32656044
http://dx.doi.org/10.7759/cureus.9038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343298/
https://www.ncbi.nlm.nih.gov/pubmed/32656044
http://dx.doi.org/10.7759/cureus.9038

Ejemplares similares